Clinical Trial Update: Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating a GPC3-targeted PET imaging agent for hepatocellular carcinoma is currently recruiting to assess its clinical application value.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Malignant Neoplasm of Liver | EARLY_Phase 1 | Status: RECRUITING